MacroGenics, Inc. (MGNX)
4.135
+0.06
(+1.35%)
USD |
NASDAQ |
Aug 28, 16:00
4.03
-0.10
(-2.54%)
After-Hours: 17:48
MacroGenics Shareholders Equity (Quarterly) : 42.87M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.87M |
| March 31, 2026 | 21.20M |
| December 31, 2025 | 55.59M |
| September 30, 2025 | 67.00M |
| June 30, 2025 | 46.62M |
| March 31, 2025 | 79.12M |
| December 31, 2024 | 116.06M |
| September 30, 2024 | 120.07M |
| June 30, 2024 | 57.82M |
| March 31, 2024 | 106.15M |
| December 31, 2023 | 152.61M |
| September 30, 2023 | 193.98M |
| June 30, 2023 | 171.54M |
| March 31, 2023 | 109.27M |
| December 31, 2022 | 142.01M |
| September 30, 2022 | 122.96M |
| June 30, 2022 | 142.48M |
| March 31, 2022 | 178.21M |
| December 31, 2021 | 239.62M |
| September 30, 2021 | 291.44M |
| June 30, 2021 | 319.04M |
| March 31, 2021 | 350.53M |
| December 31, 2020 | 295.88M |
| September 30, 2020 | 291.58M |
| June 30, 2020 | 247.78M |
| Date | Value |
|---|---|
| March 31, 2020 | 190.57M |
| December 31, 2019 | 230.63M |
| September 30, 2019 | 255.20M |
| June 30, 2019 | 294.45M |
| March 31, 2019 | 320.62M |
| December 31, 2018 | 242.88M |
| September 30, 2018 | 282.64M |
| June 30, 2018 | 312.04M |
| March 31, 2018 | 247.28M |
| December 31, 2017 | 299.24M |
| September 30, 2017 | 189.46M |
| June 30, 2017 | 231.35M |
| March 31, 2017 | 234.64M |
| December 31, 2016 | 268.75M |
| September 30, 2016 | 300.10M |
| June 30, 2016 | 329.98M |
| March 31, 2016 | 286.26M |
| December 31, 2015 | 313.34M |
| September 30, 2015 | 339.33M |
| June 30, 2015 | 211.69M |
| March 31, 2015 | 230.99M |
| December 31, 2014 | 121.29M |
| September 30, 2014 | 139.09M |
| June 30, 2014 | 141.98M |
| March 31, 2014 | 153.22M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -5.935B |
| Gilead Sciences, Inc. | 11.83B |
| Xencor, Inc. | 503.23M |
| Akari Therapeutics Plc | 18.60M |
| Janux Therapeutics, Inc. | 927.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 345.41M |
| Total Liabilities (Quarterly) | 302.54M |
| Debt to Equity Ratio | 4.624 |
| Current Ratio | 2.956 |
| Net Debt Paydown Yield | -10.94% |